ConductScience.org, home

Paper39724461

The influence of microbiota on the efficacy and toxicity of immunotherapy in cancer treatment.

Mahmoudian F and 4 others. Mol Biol Rep, 2024. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. The influence of microbiota on the efficacy and toxicity of immunotherapy in cancer treatment. Papers, record 39724461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39724461

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The influence of microbiota on the efficacy and toxicity of immunotherapy in cancer treatment.
PubMed
Journal
Mol Biol Rep
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
1.06, provisional
iCite
Revised in PubMed
2026-11-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mahmoudian FFatemeh
2Gheshlagh SRSolaleh Rezanavaz
3Hemati MMaral
4Farhadi SShabnam
5Eslami MMajidhttps://orcid.org/0000-0001-5118-678X

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DysbiosisMajor topic
Gastrointestinal MicrobiomeMajor topic
ImmunotherapyMajor topic
NeoplasmsMajor topic
Animals
Humans
Fecal Microbiota Transplantation

Source PubMed

Download CSV of topics

References84

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133303685Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients.Science2021https://conductscience.org/library/papers/33303685PubMed
236143126Composition of the Gut Microbiota Associated with the Response to Immunotherapy in Advanced Cancer Patients: A Chinese Real-World Pilot Study.J Clin Med2022https://conductscience.org/library/papers/36143126PubMed
337602831Faecalibacterium prausnitzii Abrogates Intestinal Toxicity and Promotes Tumor Immunity to Increase the Efficacy of Dual CTLA4 and PD-1 Checkpoint Blockade.Cancer Res2023https://conductscience.org/library/papers/37602831PubMed
437179402Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.Signal Transduct Target Ther2023https://conductscience.org/library/papers/37179402PubMed
532376136Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.Eur Urol2020https://conductscience.org/library/papers/32376136PubMed
636134612Probiotic immunonutrition impacts on colon cancer immunotherapy and prevention.Eur J Cancer Prev2023https://conductscience.org/library/papers/36134612PubMed
728187290Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy.Cell2017https://conductscience.org/library/papers/28187290PubMed
838870711Cause and consequence of heterogeneity in human mesenchymal stem cells: Challenges in clinical application.Pathol Res Pract2024https://conductscience.org/library/papers/38870711PubMed
939141261Clinical characteristics, treatment, and outcomes of pembrolizumab-induced uveitis.Invest New Drugs2024https://conductscience.org/library/papers/39141261PubMed
1036339577Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an aβ25-35-induced rat model of Alzheimer's disease.Front Pharmacol2022https://conductscience.org/library/papers/36339577PubMed
1138840029Exploiting bacteria for cancer immunotherapy.Nat Rev Clin Oncol2024https://conductscience.org/library/papers/38840029PubMed
1236309208Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy.Gastroenterology2023https://conductscience.org/library/papers/36309208PubMed
1337227176Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies.Clin Cancer Res2023https://conductscience.org/library/papers/37227176PubMed
1436003049Dermatophagoides pteronyssinus allergen Der p 22: Cloning, expression, IgE-binding in asthmatic children, and immunogenicity.Pediatr Allergy Immunol2022https://conductscience.org/library/papers/36003049PubMed
1534873013Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers.J Immunother Cancer2021https://conductscience.org/library/papers/34873013PubMed
1634200997The Evolution of Cancer Immunotherapy.Vaccines (Basel)2021https://conductscience.org/library/papers/34200997PubMed
1729255057Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade.Proc Natl Acad Sci U S A2018https://conductscience.org/library/papers/29255057PubMed
1831564086Optimal body mass index for minimizing the risk for osteoporosis and type 2 diabetes.Korean J Intern Med2020https://conductscience.org/library/papers/31564086PubMed
1937465523Effects of Litsea cubeba essential oil on growth performance, blood antioxidation, immune function, apparent digestibility of nutrients, and fecal microflora of pigs.Front Pharmacol2023https://conductscience.org/library/papers/37465523PubMed
2038035338Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/38035338PubMed

See all 84 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
41597216VERU-111 Promotes an Anti-Tumor Response Through Restoration of Gut Microbial Homeostasis and Associated Metabolic Dysregulation.Cells2026https://conductscience.org/library/papers/41597216PubMed
41300985Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components.Cancers (Basel)2025https://conductscience.org/library/papers/41300985PubMed
41186720The gut-brain axis: role of gut microbiota in neurological disease pathogenesis and pharmacotherapeutics.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/41186720PubMed
40927726Gut dysbiosis in cancer immunotherapy: microbiota-mediated resistance and emerging treatments.Front Immunol2025https://conductscience.org/library/papers/40927726PubMed
40564016The Microbiome Connection: A Common Pathway Linking Cancer and Heart Failure.Biomedicines2025https://conductscience.org/library/papers/40564016PubMed
40406094Microbiota as diagnostic biomarkers: advancing early cancer detection and personalized therapeutic approaches through microbiome profiling.Front Immunol2025https://conductscience.org/library/papers/40406094PubMed
40136508The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions.Biology (Basel)2025https://conductscience.org/library/papers/40136508PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39724461

GET https://conductscience.org/api/papers/v1/39724461/references?page=2